glp 1 injection in thigh GLP-1 Analogues Nail your shot with the

Is the most common

Phase III studies are ongoing to further investigate the efficacy and safety of survodutide in obesity management

The ATTAIN-1 trial , set for July 2025, is evaluating weight loss in people with obesity or overweight who have weight-related health conditions

Who It Is Not For Anyone expecting prescription-drug-level weight loss will be disappointed

All of this also shouldnt be super surprising

[13] Insulin, for instance, requires multiple daily injections, which can be challenging for patients, [14] and while metformin is generally well-tolerated, its safety profile remains somewhat controversial, as it crosses the placenta